Anti-VEGF Monoclonal Antibody(Bevacizumab)

产品型号：S0B0557

更新时间：2025-08-09

厂商性质：生产厂家

访问量：76

服务热线

15855403091

立即咨询

产品分类

PRODUCT CLASSIFICATION

抗体/抗原

ELISA试剂盒抗体试剂盒二抗试剂盒二抗其它流式抗体琼脂糖/磁珠偶联抗体抗Payload抗体泛修饰抗体标签/内参抗体功能性抗体 Biosimilar抗体偶联抗体配对抗体病理/IHC抗体

查看全部产品

PI3K-Akt 信号通路：解码癌细胞的 “生存引擎” 与靶向治疗新方向

IHC肿瘤标志物 | 常见肺癌诊断

1h快速定量Total IgG

重组人糜蛋白酶的储存条件与制剂配方研究

产品介绍

Bevacizumab works by blocking a protein called VEGF, which some cancer cells produce in large amounts. Blocking VEGF may prevent the growth of new blood vessels that tumors need to grow. Bevacizumab is a type of targeted therapy called an angiogenesis inhibitor. For cancer, it is given by slow injection into a vein （intravenous） and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye （intravitreal）.

上一个：S0B0558Anti-EGFR Monoclonal Antibody(Cetuximab)